Clinical trial Recruiting at 1 site Interventional Ages 1 Year to 17

Mastery-learning inhaler training for parents of children treated for breathing problems in the pediatric emergency unit

Official title: Evaluation of the Effectiveness of an Education Program Based on the Mastery Learning Theory for Parents of Children Receiving Inhaler Therapy: A Pediatric Emergency Department Example

Run by Zonguldak Bulent Ecevit University · NCT07452731 · Data updated 2026-11-12

This program will try a hands-on mastery learning education for parents of children who need inhaler treatment in the emergency department to improve how inhalers are given.

More Shortness of Breath trials

Quick facts

Study typeInterventional
Ages1 Year to 17 Years
SexAll
Enrollment80 (estimated)
SponsorZonguldak Bulent Ecevit University
Academic / other
Locations1 site (Ankara)
StatusRecruiting
StartedNovember 5, 2025
Main results expectedNovember 5, 2026
Study endsJune 6, 2027
Registry record updatedMarch 5, 2026
Trial IDNCT07452731 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children receiving inhaler medication in the pediatric emergency unit whose mother is literate, speaks Turkish, has no communication barriers, and agrees to participate are the ideal candidates.

Probably not a fit

Children or parents who cannot speak Turkish, whose mothers have communication or literacy barriers, or children with facial anatomical issues or life‑threatening conditions may not benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project has two phases: first the research team will develop and validate an Inhaler Therapy Application Checklist with experts and statistical testing of its measurements. In the second phase, parents of children receiving inhaler medication in the pediatric emergency department will have their baseline inhaler-administration skills rated and then receive a mastery-learning education program or routine care, with skills rechecked. Data will be collected at İhsan Doğramacı Children's Hospital between October 2025 and October 2026 to measure changes in parent technique and checklist reliability. The intervention emphasizes repeated practice, feedback, and demonstration until parents reach a predefined mastery level.

Why it matters

Potential benefit: If successful, parents will use inhalers more correctly, which could improve children's symptom control and reduce respiratory complications and return visits.

How similar studies have gone: Previous educational and technology-based inhaler training programs have improved inhaler technique, though mastery-learning applied specifically in the pediatric emergency setting is less commonly tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* \- Child is receiving inhaler medication.
* Child has no intellectual or neurological disability.
* Child has no facial anatomical defects affecting inhaler use.
* Child has no life-threatening conditions.
* Both mother and child can speak Turkish.
* Mother has no communication barriers (e.g., mental capacity intact).
* Mother is literate.
* Voluntary participation in the study

Exclusion Criteria:

Refusal to participate in the study.

* Incomplete data provision.

Where it's running

  • İhsan Doğramacı Children's Hospital
    Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.